MetLife Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Los beneficios de MetLife han disminuido a una tasa media anual de -8%, mientras que en la industria Insurance los beneficios crecieron en un 14.6% anualmente. Los ingresos han ido creciendo a una tasa media de 1.9% al año. La rentabilidad financiera de MetLife es de 13%, y sus márgenes netos son de 4.4%.
Información clave
-8.02%
Tasa de crecimiento de los beneficios
-1.48%
Tasa de crecimiento del BPA
| Crecimiento de la industria Insurance | 8.02% |
| Tasa de crecimiento de los ingresos | 1.87% |
| Rentabilidad financiera | 13.00% |
| Margen neto | 4.43% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Artículo de análisis • Jun 17
MetLife (MET) Stock Could Be 47% Below Fair Value After New Settlement Product
MetLife’s new deferred payment solution puts product design in focus MetLife (MET) recently introduced the Non-Qualified Assignment Flex Agreement, or NQA-FA, a deferred payment solution that gives attorneys and brokers more control over the timing and structure of non-physical injury settlements. The NQA-FA uses a funding agreement rather than an annuity and supports features such as deferred start dates, lump sums and customized payment schedules, potentially broadening how MetLife stock...
Actualización de narrativa • Jun 09
MET: Capital Returns And Product Flexibility Will Shape Future Risk Reward Balance
Analysts have raised their price target on MetLife to $92.80 from $89.31, citing updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E estimates. What's in the News MetLife reported Q1 2026 adjusted earnings growth of 18% year over year, with broad top line growth across all operating segments and resilient margins, supported by expanding businesses in Asia, Latin America, Group Benefits, and Retirement and Income Solutions.Seeking Alpha • Jun 08
MetLife: Not Exciting, But It Works
Summary MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends. Key risks include commercial mortgage exposure and volatile alternative investment income, but preferred dividend coverage remains exceptionally strong. Read the full article on Seeking AlphaActualización de narrativa • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Actualización de narrativa • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).Actualización de narrativa • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.Actualización de narrativa • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).Actualización de narrativa • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.Actualización de narrativa • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.Actualización de narrativa • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.Actualización de narrativa • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.Actualización de narrativa • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.Actualización de narrativa • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaDesglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero MetLife. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 77,584 | 3,434 | 0 | 0 |
| 31 Dec 25 | 77,079 | 3,173 | 0 | 0 |
| 30 Sep 25 | 71,932 | 3,634 | 0 | 0 |
| 30 Jun 25 | 73,011 | 4,091 | 0 | 0 |
| 31 Mar 25 | 73,494 | 4,305 | 0 | 0 |
| 31 Dec 24 | 70,982 | 4,226 | 0 | 0 |
| 30 Sep 24 | 71,340 | 3,561 | 0 | 0 |
| 30 Jun 24 | 68,767 | 2,708 | 0 | 0 |
| 31 Mar 24 | 67,570 | 2,166 | 0 | 0 |
| 31 Dec 23 | 66,901 | 1,380 | 0 | 0 |
| 30 Sep 23 | 63,479 | 2,355 | 0 | 0 |
| 30 Jun 23 | 69,896 | 3,031 | 0 | 0 |
| 31 Mar 23 | 68,747 | 3,542 | 0 | 0 |
| 31 Dec 22 | 68,764 | 5,099 | 0 | 0 |
| 30 Sep 22 | 73,251 | 4,726 | 0 | 0 |
| 30 Jun 22 | 67,873 | 5,149 | 0 | 0 |
| 31 Mar 22 | 70,923 | 7,634 | 0 | 0 |
| 31 Dec 21 | 68,688 | 6,654 | 0 | 0 |
| 30 Sep 21 | 70,409 | 5,301 | 0 | 0 |
| 30 Jun 21 | 69,519 | 4,413 | 0 | 0 |
| 31 Mar 21 | 65,094 | 1,115 | 0 | 0 |
| 31 Dec 20 | 67,842 | 5,191 | 0 | 0 |
| 30 Sep 20 | 65,567 | 5,603 | 0 | 0 |
| 30 Jun 20 | 68,230 | 7,122 | 0 | 0 |
| 31 Mar 20 | 71,628 | 8,738 | 0 | 0 |
| 31 Dec 19 | 69,620 | 5,721 | 0 | 0 |
| 30 Sep 19 | 68,139 | 7,195 | 0 | 0 |
| 30 Jun 19 | 65,750 | 5,923 | 0 | 0 |
| 31 Mar 19 | 69,438 | 5,084 | 0 | 0 |
| 31 Dec 18 | 67,941 | 4,982 | 0 | 0 |
| 30 Sep 18 | 68,112 | 5,244 | -252 | 0 |
| 30 Jun 18 | 67,980 | 5,235 | -166 | 0 |
| 31 Mar 18 | 62,119 | 5,197 | 0 | 0 |
| 31 Dec 17 | 62,308 | 4,893 | 0 | 0 |
| 30 Sep 17 | 59,263 | 1,893 | -33 | 0 |
| 30 Jun 17 | 58,908 | 2,044 | -28 | 0 |
| 31 Mar 17 | 57,263 | 2,229 | -97 | 0 |
| 31 Dec 16 | 60,732 | 3,481 | 0 | 0 |
| 30 Sep 16 | 65,209 | 4,994 | 368 | 0 |
| 30 Jun 16 | 67,255 | 5,169 | 355 | 0 |
| 31 Mar 16 | 69,952 | 5,219 | 342 | 0 |
| 31 Dec 15 | 61,257 | 3,891 | 0 | 0 |
| 30 Sep 15 | 71,888 | 5,857 | 333 | 0 |
| 30 Jun 15 | 72,677 | 6,724 | 350 | 0 |
Ingresos de calidad: MET tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(4.4%) de MET son inferiores a los del año pasado (5.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de MET han disminuido en un 8% al año en los últimos 5 años.
Acelerando crecimiento: MET ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: MET tuvo un crecimiento negativo de los beneficios (-20.2%) durante el año pasado, lo que dificulta la comparación con la media de la industria Insurance (36.5%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de MET (13%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/20 19:25 |
| Precio de las acciones al final del día | 2026/06/18 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
MetLife, Inc. está cubierta por 31 analistas. 9 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |